美罗华
医学
内科学
耐受性
中止
视神经脊髓炎
不利影响
扩大残疾状况量表
胃肠病学
抗体
免疫学
多发性硬化
淋巴瘤
标识
DOI:10.1001/archneurol.2011.154
摘要
Repeated treatment with rituximab appeared to produce consistent and sustained efficacy over 24 months with good tolerability in patients with NMO.
科研通智能强力驱动
Strongly Powered by AbleSci AI